查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1541258

2024-2032 年按治療類別、類型、配銷通路和地區分類的抗高血壓藥物市場報告

Antihypertensive Drugs Market Report by Therapeutic Class, Type, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2023年全球抗高血壓藥物IMARC Group規模達297億美元。高血壓盛行率的增加、心血管疾病患者數量的增加以及臨床研究數量的增加是推動市場發展的一些關鍵因素。

抗高血壓藥物用於治療高血壓，血液對動脈壁的壓力變大，並可能增加心臟病、中風和其他健康問題的風險。它們通常包括利尿劑、BETA-阻斷劑、鈣通道阻斷劑、血管緊張素轉換酶(ACE)抑制劑和血管擴張劑。它們的作用是放鬆血管、減少血管中的液體量以及減少導致血管收縮的荷爾蒙量。它們還能減慢心跳，維持健康的收縮壓，提高預期壽命，並最大限度地降低過早死亡的風險。目前，主要參與者正在推出咪唑啉、莫那皮爾和中性內肽酶抑制劑來擴大其產品組合。

抗高血壓藥物市場趨勢：

高血壓和高血壓在個人中的盛行率激增是推動全球抗高血壓藥物需求的主要因素之一。此外，容易患這些疾病的老年人口不斷增加，正在對市場產生積極影響。此外，由於久坐的生活方式、不健康的飲食模式、高壓力水平、糖尿病和肥胖，導致心血管疾病（CVD）患者數量不斷增加，有利於市場的成長。除此之外，許多國家的管理機構正在發起運動，以提高人們對高血壓疾病、其症狀、診斷和治療的認知。再加上開發高血壓新療法的臨床研究和試驗數量不斷增加，正在加強市場的成長。此外，由於醫療費用不斷增加，擴大使用非處方藥（OTC）來治療血壓相關疾病，這為市場創造了積極的前景。除此之外，根據消費者所需劑量提供抗高血壓藥物的線上零售平台數量有所增加。這加上製藥和電子商務行業的顯著成長，正在推動市場的成長。此外，擴大採用為高血壓治療提供經濟援助並最大限度地減少醫療費用的健康保險政策正在推動市場的成長。

本報告回答的關鍵問題：

  • 迄今為止，全球抗高血壓藥物市場表現如何，未來幾年將如何表現？
  • 全球抗高血壓藥物市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球抗高血壓藥物市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的抗高血壓藥物市場？
  • 基於治療類別的市場區隔是什麼？
  • 抗高血壓藥物市場上最具吸引力的治療類別是什麼？
  • 依類型分類市場是怎麼樣的？
  • 降血壓藥市場上哪一類最具吸引力？
  • 基於配銷通路的市場區隔是什麼？
  • 降血壓藥市場上最具吸引力的配銷通路是哪一個？
  • 全球降血壓藥市場競爭格局如何？
  • 全球抗高血壓藥物市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球抗高血壓藥物市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依治療類別

  • 利尿劑
    • 市場趨勢
    • 市場預測
  • ACE抑制劑
    • 市場趨勢
    • 市場預測
  • 鈣通道阻斷劑
    • 市場趨勢
    • 市場預測
  • BETA-腎上腺素阻斷劑
    • 市場趨勢
    • 市場預測
  • 血管擴張劑
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：按類型

  • 原發性高血壓
    • 市場趨勢
    • 市場預測
  • 繼發性高血壓
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：按配銷通路

  • 零售藥房
    • 市場趨勢
    • 市場預測
  • 醫院藥房
    • 市場趨勢
    • 市場預測
  • 電子商務
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • AstraZeneca
    • Boehringer Ingelheim International GmbH
    • Daiichi Sankyo Company Limited
    • Johnson & Johnson Services Inc.
    • Lupin Pharmaceuticals Inc
    • Merck & Co. Inc.
    • Novartis AG
    • Pfizer Inc.
    • Sanofi
    • Sun Pharmaceutical Industries Ltd.
Product Code: SR112024A4190

The global antihypertensive drugs market size reached US$ 29.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 38.0 Billion by 2032, exhibiting a growth rate (CAGR) of 2.7% during 2024-2032. The increasing prevalence of hypertension, rising number of patients suffering from CVDs, and the growing number of clinical studies represent some of the key factors driving the market.

Antihypertensive drugs are utilized to treat hypertension wherein the force of blood against the walls of the arteries becomes high and can increase the risk of heart disease, stroke, and other health problems. They generally comprise diuretics, beta-blockers, calcium channel blockers, angiotensin-converting enzyme (ACE) inhibitors, and vasodilators. They work by relaxing the blood vessels, reducing the amount of fluid in the blood vessels, and decreasing the amount of hormones that cause blood vessels to constrict. They also slow down the heartbeat, maintain a healthy systolic BP, improve life expectancy, and minimize the risk of premature death. At present, key players are introducing imidazolines, monatepil, and neutral endopeptidase inhibitors to expand their product portfolio.

Antihypertensive Drugs Market Trends:

The surging prevalence of hypertension and high BP among individuals represents one of the major factors driving the demand for antihypertensive drugs around the world. Moreover, the growing geriatric population that is susceptible to developing these medical disorders is influencing the market positively. In addition, the increasing number of patients suffering from cardiovascular diseases (CVDs) on account of sedentary lifestyles, unhealthy dietary patterns, high-stress levels, diabetes, and obesity among the masses is favoring the growth of the market. Apart from this, governing agencies of numerous countries are initiating campaigns to spread awareness about the hypertension disorder, its symptoms, diagnosis, and treatment. This, coupled with the rising number of clinical studies and trials to develop new treatments for hypertension, is strengthening the growth of the market. Furthermore, the growing usage of over the counter (OTC) drugs to treat BP-related diseases on account of expanding healthcare costs is creating a positive outlook for the market. Besides this, there is a rise in the number of online retail platforms that offer antihypertensive drugs according to the dosage needed by the consumer. This, along with significant growth in the pharmaceutical and e-commerce industries, is propelling the growth of the market. Additionally, the increasing adoption of health insurance policies that provide financial assistance for hypertension treatment and minimize healthcare expenses is impelling the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global antihypertensive drugs market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on therapeutic class, type and distribution channel.

Therapeutic Class Insights:

Diuretics

ACE Inhibitors

Calcium Channel Blockers

Beta-adrenergic Blockers

Vasodilators

Others

The report has provided a detailed breakup and analysis of the antihypertensive drugs market based on the therapeutic class. This includes diuretics, ACE inhibitors, calcium channel blockers, beta-adrenergic blockers, vasodilators, and others. According to the report, calcium channel blockers represented the largest segment.

Type Insights:

Primary Hypertension

Secondary Hypertension

A detailed breakup and analysis of the antihypertensive drugs market based on the type has also been provided in the report. This includes primary hypertension and secondary hypertension. According to the report, primary hypertension accounted for the largest market share.

Distribution Channel Insights:

Retail Pharmacy

Hospital Pharmacy

E-Commerce

The report has provided a detailed breakup and analysis of the antihypertensive drugs market based on the distribution channel. This includes retail pharmacy, hospital pharmacy, and e-commerce. According to the report, hospital pharmacy represented the largest segment.

Regional Insights:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for antihypertensive drugs. Some of the factors driving the North America antihypertensive drugs market included expansion of online pharmacies, government initiatives, product innovation, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global antihypertensive drugs market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include AstraZeneca, Boehringer Ingelheim International GmbH, Daiichi Sankyo Company Limited, Johnson & Johnson Services Inc., Lupin Pharmaceuticals Inc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global antihypertensive drugs market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global antihypertensive drugs market?
  • What is the impact of each driver, restraint, and opportunity on the global antihypertensive drugs market?
  • What are the key regional markets?
  • Which countries represent the most attractive antihypertensive drugs market?
  • What is the breakup of the market based on the therapeutic class?
  • Which is the most attractive therapeutic class in the antihypertensive drugs market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the antihypertensive drugs market?
  • What is the breakup of the market based on the distribution channel?
  • Which is the most attractive distribution channel in the antihypertensive drugs market?
  • What is the competitive structure of the global antihypertensive drugs market?
  • Who are the key players/companies in the global antihypertensive drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Antihypertensive Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Therapeutic Class

  • 6.1 Diuretics
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 ACE Inhibitors
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Calcium Channel Blockers
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Beta-adrenergic Blockers
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Vasodilators
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Type

  • 7.1 Primary Hypertension
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Secondary Hypertension
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Retail Pharmacy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospital Pharmacy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 E-Commerce
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AstraZeneca
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Boehringer Ingelheim International GmbH
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Daiichi Sankyo Company Limited
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Johnson & Johnson Services Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Lupin Pharmaceuticals Inc
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Merck & Co. Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Novartis AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Pfizer Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Sanofi
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Sun Pharmaceutical Industries Ltd.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Antihypertensive Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Antihypertensive Drugs Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Antihypertensive Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Antihypertensive Drugs Market: Breakup by Therapeutic Class (in %), 2023
  • Figure 5: Global: Antihypertensive Drugs Market: Breakup by Type (in %), 2023
  • Figure 6: Global: Antihypertensive Drugs Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Antihypertensive Drugs Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Antihypertensive Drugs (Diuretics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Antihypertensive Drugs (Diuretics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Antihypertensive Drugs (ACE Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Antihypertensive Drugs (ACE Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Antihypertensive Drugs (Calcium Channel Blockers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Antihypertensive Drugs (Calcium Channel Blockers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Antihypertensive Drugs (Beta-adrenergic Blockers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Antihypertensive Drugs (Beta-adrenergic Blockers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Antihypertensive Drugs (Vasodilators) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Antihypertensive Drugs (Vasodilators) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Antihypertensive Drugs (Other Therapeutic Classes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Antihypertensive Drugs (Other Therapeutic Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Antihypertensive Drugs (Primary Hypertension) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Antihypertensive Drugs (Primary Hypertension) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Antihypertensive Drugs (Secondary Hypertension) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Antihypertensive Drugs (Secondary Hypertension) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Antihypertensive Drugs (Retail Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Antihypertensive Drugs (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Antihypertensive Drugs (Hospital Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Antihypertensive Drugs (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Antihypertensive Drugs (E-Commerce) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Antihypertensive Drugs (E-Commerce) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: North America: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: North America: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: United States: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: United States: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Canada: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Canada: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Asia-Pacific: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Asia-Pacific: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: China: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: China: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Japan: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Japan: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: India: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: India: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: South Korea: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: South Korea: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Australia: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Australia: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Indonesia: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Indonesia: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Others: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Others: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Europe: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Europe: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Germany: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Germany: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: France: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: France: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: United Kingdom: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: United Kingdom: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Italy: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Italy: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Spain: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Spain: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Russia: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Russia: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Latin America: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Latin America: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Brazil: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Brazil: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Mexico: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Mexico: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Middle East and Africa: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Middle East and Africa: Antihypertensive Drugs Market: Breakup by Country (in %), 2023
  • Figure 78: Middle East and Africa: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Global: Antihypertensive Drugs Industry: SWOT Analysis
  • Figure 80: Global: Antihypertensive Drugs Industry: Value Chain Analysis
  • Figure 81: Global: Antihypertensive Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Antihypertensive Drugs Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Antihypertensive Drugs Market Forecast: Breakup by Therapeutic Class (in Million US$), 2024-2032
  • Table 3: Global: Antihypertensive Drugs Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 4: Global: Antihypertensive Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Antihypertensive Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Antihypertensive Drugs Market: Competitive Structure
  • Table 7: Global: Antihypertensive Drugs Market: Key Players